Rankings
▼
Calendar
NAUT Q4 2019 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$289M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$355,000
Net Income
$385,490
EPS (Diluted)
$0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$88,992
Free Cash Flow
-$88,992
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$19M
Total Liabilities
$490,000
Stockholders' Equity
$18M
Cash & Equivalents
$595,000
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$355,000
-$112M
+99.7%
Net Income
$385,490
$627M
-99.9%
← FY 2019
All Quarters
Q1 2020 →